Ataxia telangiectasia mutated kinase
Showing 26 - 50 of 3,009
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Dabrafenib
- MEK-1/MEKK-1 Inhibitor E6201
-
Scottsdale, Arizona
- +2 more
Jan 4, 2023
Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United
Recruiting
- Metastatic Lung Small Cell Carcinoma
- +16 more
- Elimusertib
- +2 more
-
Phoenix, Arizona
- +10 more
Mar 25, 2022
Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in United States (Lanraplenib,
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Los Angeles, California
- +3 more
Aug 4, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)
Recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Iadademstat
- Gilteritinib Oral Tablet
-
Boston, Massachusetts
- +2 more
Jan 18, 2023
Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States
Not yet recruiting
- Anatomic Stage I Breast Cancer
- +3 more
- Endocrine Therapy
- +7 more
-
Atlanta, Georgia
- +4 more
Jun 15, 2023
Blood Pressure, Lung Function, Inflammation Trial in Beijing (Air cleaner use method 1, Air cleaner use method 2)
Completed
- Blood Pressure
- +3 more
- Air cleaner use method 1
- Air cleaner use method 2
-
Beijing, ChinaDepartment of Occupational & Environmental Health Sciences, Scho
Oct 7, 2021
Ataxia Telangiectasia Louis-Bar, Ataxia Telangiectasia in Children, Ataxia Telangiectasia Trial in Houston (MBM-01)
Not yet recruiting
- Ataxia Telangiectasia Louis-Bar
- +2 more
-
Houston, TexasUniversity of Texas Health Science Center at Houston
May 13, 2021
Multiple Sclerosis, Ataxia Trial in Giza (physical therapy, life kinetic exercises)
Completed
- Multiple Sclerosis
- Ataxia
- physical therapy
- life kinetic exercises
-
Giza, EgyptFaculty of Physical Therapy
Aug 18, 2023
Lung Cancer Metastatic, EGFR Gene Mutation Trial in San Francisco (Osimertinib, Alisertib)
Recruiting
- Lung Cancer Metastatic
- EGFR Gene Mutation
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 10, 2022
Hereditary Haemorrhagic Telangiectasia Trial in Bron, Clermont-Ferrand, Montpellier (Cord blood sampling, Cord sampling)
Not yet recruiting
- Hereditary Haemorrhagic Telangiectasia
- Cord blood sampling
- Cord sampling
-
Bron, France
- +2 more
Nov 21, 2022
Ataxia, Degenerative Disease, Genetic Disease Trial in Saint-Didier-au-Mont-d'Or, Saint-Genis-Laval, Saint-Étienne (PAMPERO
Not yet recruiting
- Ataxia
- +2 more
- PAMPERO program
-
Saint-Didier-au-Mont-d'Or, France
- +2 more
Oct 17, 2023
NSCLC Stage IIIB~IV Trial in Taipei (Atezolizumab Injection; bevacizumab Injection)
Recruiting
- NSCLC Stage IIIB~IV
- Atezolizumab Injection; bevacizumab Injection
-
Taipei, TaiwanNational Taiwan University Hospital
Jan 18, 2022
Nervous System Disease, Genetic Syndrome Trial in Worldwide (EDS-EP dose range of ~5-10 mg DSP/infusion, EDS-EP dose range of
Completed
- Nervous System Disease
- Genetic Syndrome
- EDS-EP dose range of ~5-10 mg DSP/infusion
- +2 more
-
Los Angeles, California
- +21 more
Aug 6, 2021
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide (gilteritinib, LoDAC (Low Dose
Active, not recruiting
- Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
- gilteritinib
- +3 more
-
Beijing, China
- +47 more
Aug 17, 2022
Hereditary Ataxia, Spinocerebellar Degenerations, Cerebellar Ataxia Trial (Therapeutic core stability exercises)
Not yet recruiting
- Hereditary Ataxia
- +2 more
- Therapeutic core stability exercises
- (no location specified)
Nov 21, 2023
Cerebellar Ataxia Trial in Giza (motor imaginary training, physical therapy training)
Completed
- Cerebellar Ataxia
- motor imaginary training
- physical therapy training
-
Giza, EgyptReham Alsakhawi
Aug 7, 2023
Friedreich Ataxia Trial in Worldwide (Omaveloxolone Capsules, 2.5 mg, Omaveloxolone Capsules, 5 mg, Omaveloxolone Capsules, 10
Active, not recruiting
- Friedreich Ataxia
- Omaveloxolone Capsules, 2.5 mg
- +9 more
-
Los Angeles, California
- +10 more
Dec 2, 2022
Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis
Completed
- Transthyretin Amyloidosis
- No intervention,
-
Nîmes, FranceCHU de Nîmes
Sep 1, 2022